Anil K Giri

Anil K Giri

Helsingin yliopisto

H-index: 18

Europe-Finland

About Anil K Giri

Anil K Giri, With an exceptional h-index of 18 and a recent h-index of 18 (since 2020), a distinguished researcher at Helsingin yliopisto, specializes in the field of Pharmacogenomics, Cancer Genetics, Drug Combination.

His recent articles reflect a diverse array of research interests and contributions to the field:

Genome-wide mRNA profiling in urinary extracellular vesicles reveals stress gene signature for diabetic kidney disease

Molecular signatures for gene expression in Mycobacterium leprae: A bioinformatic analysis

Single-cell transcriptomes identify patient-tailored therapies for selective co-inhibition of cancer clones

Genome-Wide Association Study Identifies 4 Novel Risk Loci for Small Intestinal Neuroendocrine Tumors Including a Missense Mutation in LGR5

Epigenome-wide methylation study identified two novel CpGs associated with T2DM risk and a network of co-methylated CpGs capable of patient’s classifications

High-throughput screening for drug discovery targeting the cancer cell-microenvironment interactions in hematological cancers

SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples

Fully-automated and ultra-fast cell-type identification using specific marker combinations from single-cell transcriptomic data

Anil K Giri Information

University

Position

___

Citations(all)

1853

Citations(since 2020)

1698

Cited By

504

hIndex(all)

18

hIndex(since 2020)

18

i10Index(all)

23

i10Index(since 2020)

22

Email

University Profile Page

Helsingin yliopisto

Google Scholar

View Google Scholar Profile

Anil K Giri Skills & Research Interests

Pharmacogenomics

Cancer Genetics

Drug Combination

Top articles of Anil K Giri

Title

Journal

Author(s)

Publication Date

Genome-wide mRNA profiling in urinary extracellular vesicles reveals stress gene signature for diabetic kidney disease

Iscience

Om Prakash Dwivedi

Karina Barreiro

Annemari Käräjämäki

Erkka Valo

Anil K Giri

...

2023/5/19

Molecular signatures for gene expression in Mycobacterium leprae: A bioinformatic analysis

Gene Reports

Divya RSJB Rana

Nischal Pokhrel

Anil Kumar Giri

2023/3/1

Single-cell transcriptomes identify patient-tailored therapies for selective co-inhibition of cancer clones

bioRxiv

Aleksandr Ianevski

Kristen Nader

Daria Bulava

Anil K Giri

Tanja Ruokoranta

...

2023

Genome-Wide Association Study Identifies 4 Novel Risk Loci for Small Intestinal Neuroendocrine Tumors Including a Missense Mutation in LGR5

Gastroenterology

Anil K Giri

Mervi Aavikko

Linnea Wartiovaara

Toni Lemmetyinen

Juha Karjalainen

...

2023/10/1

Epigenome-wide methylation study identified two novel CpGs associated with T2DM risk and a network of co-methylated CpGs capable of patient’s classifications

Human Molecular Genetics

Anil K Giri

Gauri Prasad

Vaisak Parekatt

Donaka Rajashekar

Nikhil Tandon

...

2023/8/15

High-throughput screening for drug discovery targeting the cancer cell-microenvironment interactions in hematological cancers

Anil K Giri

Aleksander Ianevski

2022/2/1

SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples

Nucleic acids research

Aleksandr Ianevski

Anil K Giri

Tero Aittokallio

2022/7/5

Fully-automated and ultra-fast cell-type identification using specific marker combinations from single-cell transcriptomic data

Nature communications

Aleksandr Ianevski

Anil K Giri

Tero Aittokallio

2022/3/10

Network analysis after epigenome wide methylation study revealed JUP as a regulator of co-methylated risk-module for T2DM

bioRxiv

Anil K Giri

Gauri Prasad

Vaisak Parekkat

Donaka Rajashekar

Nikhil Tandon

...

2021/7/1

Patient-tailored design for selective co-inhibition of leukemic cell subpopulations

Science advances

Aleksandr Ianevski

Jenni Lahtela

Komal K Javarappa

Philipp Sergeev

Bishwa R Ghimire

...

2021/2/19

Higher ETV5 expression associates with poor 5-florouracil-based adjuvant therapy response in colon cancer

Frontiers in Pharmacology

Anil K Giri

2021/2/9

SynToxProfiler

Aleksandr Ianevski

Sanna Timonen

Alexander Kononov

Tero Aittokallio

Anil K Giri

2020/2/1

Patient-tailored design of AML cell subpopulation-selective drug combinations

bioRxiv

Aleksandr Ianevski

Jenni Lahtela

Komal K Javarappa

Philipp Sergeev

Bishwa R Ghimire

...

2020/7/29

SynergyFinder 2.0: visual analytics of multi-drug combination synergies

Nucleic acids research

Aleksandr Ianevski

Anil K Giri

Tero Aittokallio

2020/7/2

Multifaceted genome-wide study identifies novel regulatory loci in SLC22A11 and ZNF45 for body mass index in Indians

Molecular Genetics and Genomics

Anil K Giri

Gauri Prasad

Khushdeep Bandesh

Vaisak Parekatt

Anubha Mahajan

...

2020/7

Charting the challenges behind the testing of COVID-19 in developing countries: Nepal as a case study

Anil K Giri

Divya RSJB Rana

2020/6/1

SynToxProfiler: An interactive analysis of drug combination synergy, toxicity and efficacy

PLoS computational biology

Aleksandr Ianevski

Sanna Timonen

Alexander Kononov

Tero Aittokallio

Anil K Giri

2020/2/3

ETV5 expression positively correlates with promoter methylation and predicts response for 5-FU-based adjuvant therapy response in proximal colon cancer

bioRxiv

Anil K Giri

2020/9/9

See List of Professors in Anil K Giri University(Helsingin yliopisto)